TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2025

Intermittent or Continuous Panitumumab Plus Fluorouracil, Leucovorin, and Irinotecan for First-Line Treatment of

Antonio Avallone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.